Compound search：Set keywords and then click SEARCH.
Please contact us by using the Inquiry Form
. We will ask for more details by e-mail, so just a brief description is sufficient. You can also contact us from the page that appears by clicking on the structural formula.
| SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
|---|---|---|---|---|---|
| 02138 |  | Trt-PEG135-OBz(3,5-NO2) | 133,000/0.1mg | >80% | 0.1 |
| 04621 |  | OH-PEG27-O-BODIPY | 65,600/0.3mg | >90% | 0.1 |
| 04516 |  | DMT-PEG27-O-4-BODIPY | 64,600/0.5mg | >90% | 12.2 |
| 02139 |  | Trt-PEG27-Bz(3,5-NO2) | 64,600/0.5mg | >90% | 2.5 |
| 02140 |  | Trt-PEG18-Bz(3,5-NO2) | 64,600/0.5mg | >95% | 1.2 |
| 05950 |  | Sulforhodamine bis(CO-PEG14-COOH) | 68,800/0.1mg | >95% | 1.6 |
| 06798 |  | Cy5(1-PEG3-OMe 5-SO3H 8,8-diMe 1'-PEG13-COOH 8',8'-diMe) | 133,000/0.1mg | >95% | 0.1 |
| 06461 |  | Cy5(PEG3-OMe)(PEG13-COOtBu) | 133,000/0.1mg | >95% | 0 |
| 06410 |  | Cy7(1-PEG13-COOH 5-SO3H 8,8-diMe 1'-PEG3-OMe 5'-SO3H 8',8'-diMe) | 133,000/0.1mg | >95% | 0.4 |
| 06064 |  | Cy7(1-HexCONH-PEG13-COOtBu 5-SO3H 8,8-diMe 1'-Et-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0 |
| 05947 |  | Fluorescein bis(COOH-PEG13-O-) | 65,700/0.4mg | >95% | 0.1 |
| 05373 |  | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-CONH-PEG2-Hex-Cl 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 133,000/0.1mg | >90% | 0.1 |
| 05187 |  | BODIPY-4-O-PEG13-COOtBu | 68,800/0.1mg | >95% | 3.0 |
| 05078 |  | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-COOtBu 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >90% | 0 |
| 04959 |  | BODIPY-4-O-PEG13-COOH | 105,500/0.1mg | >95% | 0.1 |
| 04746 |  | CF660R-PEG13-PEG2-O-HexCl | 133,000/0.1mg | >95% | 0.1 |
| 04731 |  | DY-547-CONH-PEG13-COOH | 69100/<0.1mg | >95% | 0.1 |
| 04730 |  | Texas-Red-X-CONH-PEG13-COOH mixed isomers | 69100/<0.1mg | >95% | 0.1 |
| 04729 |  | BODIPY FL C5-CONH-PEG13-COOH | 69100/<0.1mg | >95% | 0.1 |
| 04728 |  | 5(6)-TAMRA-CONH-PEG13-COOH | 69100/<0.1mg | >95% | 0.1 |
| 04727 |  | Cy3-CONH-PEG13-COOH | 68,800/0.1mg | >95% | 0.1 |
| 04726 |  | Cy5(1-Hex-CONH-PEG13-COOH 8,8-diMe 1'-Me 8',8'-diMe) | 69100/<0.1mg | >90% | 0.1 |
| 04722 |  | 5(6)-TAMRA-CONH-PEG13-COOtBu | 68,800/0.1mg | >95% | 0.1 |
| 04721 |  | Cy3-CONH-PEG13-COOtBu | 66,600/0.1mg | >95% | 0.1 |
| 04720 |  | Cy5(1-Hex-CONH-PEG13-COOtBu 8,8-diMe 1'-Me 8',8'-diMe) | 66,600/0.1mg | >90% | 1.5 |
| 06479 |  | Cy5(1-PEG12-OMe 5-SO3H 8,8-diMe 1'-AcOtBu-8',8'-diMe | 68,800/0.1mg | >90% | 0.4 |
| 06518 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Et 5'-SO3H 8'-Me 8'-PEG11-OMe | 68,800/0.1mg | >90% | 0 |
| 06402 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG10-OAc 5'-SO3H 8',8'-diMe) | 68,800/0.1mg | >95% | 0 |
| 02137 |  | DMT-PEG9-Bz(3,5-NO2) | 70,800/2.5mg | >95% | 6.3 |
| 02136 |  | Trt-PEG9-Bz(3,5-NO2) | 64,000/0.7mg | >95% | 19.4 |
| 02134 |  | Trt-PEG9-NH-CSNH-FITC | 68,800/0.2mg | >95% | 1.8 |
| 06516 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06432 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06417 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06426 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06419 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 05978 |  | Fluorescein bis(NH2-PEG5) | 63,400/0.2mg | >95% | 1.1 |
| 04857 |  | Sulforhodamine bis(piperazine-PEG5-COOH) | 65,700/0.4mg | >95% | 7.0 |
| 06895 |  | Cy5(1,1'-PEG4 8,8-diMe 8',8'-diMe) | 66,300/2.5mg | >95% | 2.2 |
| 06511 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 68,800/0.1mg | >90% | 0 |
| 06509 |  | 1-(5-carboxypentyl)-2-[(E,3Z)-3-[1-ethyl-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06434 |  | 2-[(E,3Z)-3-[1,3-bis[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-1-[2-[2-(2-carboxyethoxy)ethoxy]ethyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06433 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG3-OMe) | 68,800/0.1mg | >90% | 0 |
| 06422 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06409 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-N3 8',8'-diMe) | 133,000/0.1mg | >95% | 0 |
| 06062 |  | Cy7(1-PEG4-COOH 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0.1 |
| 06009 |  | Cy7(1-PEG4-COOMe 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0 |
| 05970 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-OH 8',8'-diMe) | 68,800/0.1mg | >95% | 0 |
| 04494 |  | OH-PEG4-O-4-BODIPY | 65,600/0.3mg | >95% | 0.9 |
| 04484 |  | BODIPY-4-O-PEG4-COOH | 64,600/0.5mg | >95% | 0.5 |
| 04483 |  | NH2-PEG4-O-2-BODIPY | 105,500/0.1mg | >95% | 0.1 |
| 01592 |  | NH2-NH-PEG4-CONH-Fluorescein | 76,000/0.1mg | >90% | 0.1 |
| 01591 |  | Fluorescein PEG-NH(Boc)-NH2 | 133,000/0.1mg | >95% | 0.5 |
| 00207 |  | Cy3-CONH-PEG4-O-Et-CONHPrCOOH | 65,700/0.4mg | >95% | 44.6 |
| 06512 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 68,800/0.1mg | >90% | 0 |
| 06441 |  | 3',6'-bis[2-(2-aminoethoxy)ethylamino]spiro[isobenzofuran-3,9'-xanthene]-1-one | 65,700/0.4mg | >95% | 0 |
| 06431 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06430 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06425 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06423 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06421 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06420 |  | (3R)-1-(5-carboxypentyl)-2-[(E,3E)-3-[(3S)-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06061 |  | Cy7(1-Hex-COOH 5-SO3H 8,8-diMe 1'-PEG3-OAc 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0.1 |
| 05976 |  | Fluorescein bis PEG3 | 68,800/0.1mg | >95% | 0.1 |
| 05445 |  | N-(4-bromoPEG3)-7-(diethylamino)-2-coumarine-3-carboxamide | 68,100/0.2mg | >80% | 28.0 |
| 05444 |  | N-(4-hydroxyPEG3)-7-(diethylamino)-2-coumarine-3-carboxamide | 64,600/0.5mg | >80% | 0.1 |
| 05119 |  | Fluorescein mono PEG3-OH | 66,300/2.5mg | >95% | 0.6 |
| 04477 |  | CC-PEG3-O-2-BODIPY | 64,600/0.5mg | >95% | 3.7 |
| 04475 |  | N3-PEG3-O-2-BODIPY | 64,600/0.5mg | >95% | 3.4 |
| 01345 |  | Aminolinker Fluorescein | 64,000/0.7mg | >95% | 0.1 |
| 01331 |  | Cy5(1-Hex-CONH-PEG3-NH2 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 64,000/0.7mg | >90% | 0 |
| 06515 |  | 2-[(E,3E)-3-[3,3-dimethyl-5-sulfo-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06513 |  | 3-[2-[(1E,3E,5Z)-5-[3,3-dimethyl-5-sulfo-1-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-3-[5-[2-(2-hydroxyethoxy)ethylamino]-5-oxo-pentyl]-3-methyl-5-sulfo-indol-1-ium-1-yl]propane-1-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06510 |  | Cy7(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG2-OMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 68,800/0.1mg | >95% | 0 |
| 06440 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06439 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 02819 |  | CR110-Halolinker | 68,800/0.1mg | >95% | 0.3 |
| 01979 |  | BODIPY halolinker | 105,500/0.1mg | >95% | 0.3 |
| 04622 |  | OH-PEG2K-O-BODIPY | 65,600/0.3mg | <80% | 0.5 |
| 06843 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-EtOAc 8',8'-diMe) | 63,400/0.2mg | >95% | 1.9 |
| 06840 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-EtOH 8',8'-diMe) | 65,700/0.4mg | >95% | 0.7 |
| 06523 |  | Cy7(1-PEG4-COOH 5-SO3H 8,8-di-Me 1'-PEG4-COOH 5'-SO3H 8',8'-diMe)(4-Et-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06522 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06521 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06520 |  | Cy5(1-PEG4-Pr-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PE4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >90% | 0 |
| 06519 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >95% | 0 |
| 06517 |  | 1-(4-aminobutyl)-2-[(1E,3E,5E)-5-[1-(5-carboxypentyl)-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 133,000/0.1mg | >95% | 0 |
| 06514 |  | 1-ethyl-2-[(E,3E)-3-[1-[6-(2-hydroxyethoxy)-6-oxo-hexyl]-3,3-dimethyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06496 |  | [6'-(3-chloropropanoyloxy)-3-oxo-spiro[isobenzofuran-1,9'-xanthene]-3'-yl] 3-chloropropanoate | 133,000/0.1mg | >95% | 0 |
| 06495 |  | 3-[6'-(2-carboxyethoxy)-3-oxo-spiro[isobenzofuran-1,9'-xanthene]-3'-yl]oxypropanoic acid | 133,000/0.1mg | >95% | 0 |
| 06494 |  | 3',6'-bis[(4-aminophenyl)methoxy]spiro[isobenzofuran-3,9'-xanthene]-1-one | 133,000/0.1mg | >95% | 0 |
| 06493 |  | 3',6'-bis(oxiran-2-ylmethoxy)spiro[isobenzofuran-3,9'-xanthene]-1-one | 133,000/0.1mg | >95% | 0 |
| 06492 |  | 3-[6'-(2-cyanoethoxy)-3-oxo-spiro[isobenzofuran-1,9'-xanthene]-3'-yl]oxypropanenitrile | 133,000/0.1mg | >95% | 0 |
| 06491 |  | 3',6'-bis(4-chlorobutoxy)spiro[isobenzofuran-3,9'-xanthene]-1-one | 133,000/0.1mg | >95% | 0 |
| 06490 |  | 3',6'-bis(3-sulfanylpropoxy)spiro[isobenzofuran-3,9'-xanthene]-1-one | 133,000/0.1mg | >95% | 0 |
| 06489 |  | 3',6'-bis(2-hydroxyethoxy)spiro[isobenzofuran-3,9'-xanthene]-1-one | 133,000/0.1mg | >95% | 0 |
| 06488 |  | 3',6'-bis(chloromethoxymethoxy)spiro[isobenzofuran-3,9'-xanthene]-1-one | 133,000/0.1mg | >95% | 0 |
| 06487 |  | 3',6'-bis(2-chloroethoxy)spiro[isobenzofuran-3,9'-xanthene]-1-one | 133,000/0.1mg | >95% | 0 |
| 06486 |  | 3',6'-bis(prop-2-ynoxy)spiro[isobenzofuran-3,9'-xanthene]-1-one | 133,000/0.1mg | >95% | 0 |
| 06477 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-AcOtBu 8',8'-diMe) | 133,000/0.1mg | >90% | 1.1 |
| 06446 |  | 3-[2-[2-[(2E)-2-[(E)-3-[3,3-dimethyl-1-[2-[2-(3-sulfopropoxy)ethoxy]ethyl]indol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethyl-indolin-1-yl]ethoxy]ethoxy]propane-1-sulfonic acid | 68,800/0.1mg | >95% | 0 |
| 06445 |  | 3',6'-bis(2-hydroxyethoxy)spiro[isobenzofuran-3,9'-xanthene]-1-one | 133,000/0.1mg | >95% | 0 |
| 06444 |  | 3',6'-bis(3-aminopropoxy)spiro[isobenzofuran-3,9'-xanthene]-1-one | 133,000/0.1mg | >95% | 0 |
| 06442 |  | [3-oxo-6'-(3-sulfanylpropanoyloxy)spiro[isobenzofuran-1,9'-xanthene]-3'-yl] 3-sulfanylpropanoate | 133,000/0.1mg | >95% | 0 |
| 06438 |  | Cy7(1-HexCOOH 8,8-diMe 1'-Me 8',8'-diMe)(3,5-Pr-cyclic) | 133,000/0.1mg | >95% | 0 |
| 06437 |  | BODIPY FL | 133,000/0.1mg | >95% | 0 |
| 06436 |  | 2-chloro-N-[2-[[6'-[2-[(2-chloroacetyl)amino]ethyl-methyl-amino]-3-oxo-spiro[isobenzofuran-1,9'-xanthene]-3'-yl]-methyl-amino]ethyl]acetamide | 68,800/0.1mg | >95% | 0 |
| 06435 |  | 2-iodo-N-[2-[[6'-[2-[(2-iodoacetyl)amino]ethyl-methyl-amino]-3-oxo-spiro[isobenzofuran-1,9'-xanthene]-3'-yl]-methyl-amino]ethyl]acetamide | 133,000/0.1mg | >95% | 0 |
| 06424 |  | 2-[[6'-[2-(2-aminoethoxy)ethylamino]-3-oxo-spiro[isobenzofuran-1,9'-xanthene]-3'-yl]amino]acetic acid | 68,800/0.1mg | >95% | 0 |
| 06418 |  | Cy7(1-PEG5-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >95% | 0 |
| 06416 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06296 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >90% | 0.9 |
| 05980 |  | Sulfofluorescein monoacetic acid Ac | 68,800/0.1mg | >95% | 0.3 |
| 05968 |  | 2-[4-[6'-[4-(carboxymethyl)piperazin-1-yl]-1,1-dioxo-spiro[2,1-ramda-benzoxathiole-3,9'-xanthene]-3'-yl]piperazin-1-yl]acetic acid | 68,800/0.1mg | >95% | 1.0 |
| 05967 |  | 2-[4-(1,1-dioxo-6'-piperazin-1-yl-spiro[2,1-ramda--benzoxathiole-3,9'-xanthene]-3'-yl)piperazin-1-yl]acetic acid | 68,800/0.1mg | >95% | 0 |
| 05955 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-Hex-COOH 5'-SO3H 8',8'-diMe) | 68,800/0.2mg | >90% | 0.1 |
| 05940 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Hex-COOH 5'-SO3H 8',8'-diMe) | 64,000/0.7mg | >90% | 0.5 |
| 05658 |  | Propanedinitrile, 2-[2,3-dihydro-5-[6-(1-piperazinyl)-3-pyridinyl]-1H-inden-1-ylidene]- | 64,000/5mg | >95% | 54.1 |
| 05657 |  | 1-Piperazinecarboxylic acid, 4-[5-[1-(dicyanomethylene)-2,3-dihydro-1H-inden-5-yl]-2-pyridinyl], 1,1-dimethylethyl ester | 70,000/25mg | >95% | 156.0 |
| 05654 |  | tert-butyl 4-[5-(1-oxoindan-5-yl)-2-pyridyl]piperazine-1-carboxylate | 63,400/50mg | >95% | 218.7 |
| 05651 |  | 1-Pyrenecarboxaldehyde, o-[(1,1-dimethylethylsilyl]oxime, [C(E)]- | 70,000/25mg | >95% | 422.7 |
| 05485 |  | N-(3-bromopropyl)-p-Methyl Red | 64,000/5mg | >80% | 145.4 |
| 05461 |  | N-(3-chloropropyl)-p-Methyl Red | 64,000/5mg | >80% | 64.3 |
| 05460 |  | N-(2-chloroethyl)-p-Methyl Red | 64,000/5mg | >80% | 100.7 |
| 05436 |  | N-(4-bromobutyl)-7-(diethylamino)-2-coumarine-3-carboxamide | 68,100/0.2mg | >80% | 0 |
| 05435 |  | N-(4-hydroxybutyl)-7-(diethylamino)-2-coumarine-3-carboxamide | 64,600/0.5mg | >80% | 21.0 |
| 05393 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-Et-SO3H 8',8'-diMe) | 68,800/0.1mg | >95% | 0.1 |
| 05226 |  | 1-Amino-Benzo[a]pyrene | 64,600/0.5mg | >95% | 49.4 |
| 05225 |  | Acetamide, Benzo[a]pyrene-1-yl- | 68,100/0.2mg | >95% | 72.7 |
| 05224 |  | Bis-6-o-dansyl-Mono-6-NH2-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05221 |  | Benzo[a]pyrene-1-carboxylic acid | 64,600/0.5mg | >95% | 9.1 |
| 05205 |  | Mono-6-NH2-Hexakis-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05204 |  | Mono-6-NH2-Pentakis-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05203 |  | Mono-6-NH2-Tetrakis-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 1.1 |
| 05202 |  | Mono-6-NH2-Tris-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05201 |  | Mono-6-N3-Hexakis-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >95% | 0.1 |
| 05200 |  | Mono-6-N3-Pentakis-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05199 |  | Mono-6-N3-Tetrakis-6-o-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 1.1 |
| 05195 |  | Mono-6-NH2-Bis-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 1.0 |
| 05194 |  | Mono-6-NH2-Mono-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 1.0 |
| 05190 |  | Mono-6-N3-Tris-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.2 |
| 05189 |  | Mono-6-N3-Bis-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05188 |  | Mono-6-N3-Mono-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05186 |  | Hexakis-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05185 |  | Pentakis-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05184 |  | Tetrakis-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05183 |  | Tris-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05182 |  | Bis-6-O-dansyl-beta-cyclodextrin | 76,000/0.1mg | >90% | 0.1 |
| 05181 |  | Mono-6-O-dansyl-beta-cyclodextrin | 64,600/0.5mg | >90% | 0.1 |
| 05174 |  | Bis-6-N-Dansyl-beta-cyclodextrin | 105,500/0.1mg | >95% | 2.5 |
| 05163 |  | 2-(5-(Dimethylamino)-1-naphthalenesulfonylamido)ethyl bromide | 70,000/25mg | >80% | 1,170.0 |
| 05152 |  | Florescein monoiodoacetate | 65,700/0.4mg | >95% | 0.1 |
| 05148 |  | Sulfo-Cy3 bis(IAA) | 68,800/0.2mg | >95% | 0.1 |
| 05147 |  | Sulfo Cy3-diamine | 68,800/0.2mg | >95% | 5.0 |
| 05145 |  | [6'-(Iodoacetyloxy-3-oxo-spiro[isobenzofuran-1,9'-xanthene]-3'-yl] 2-iodoacetate | 65,700/0.4mg | >95% | 0 |
| 05144 |  | 2-[6'-(2-aminoethoxy)-3-oxo-spiro[isobenzofuran-1,9'-xanthene]-3'-yl]oxyacetic acid | 65,700/0.4mg | >95% | 0 |
| 05143 |  | Sulfo-Cy3 | 65,700/0.4mg | >95% | 2.6 |
| 05139 |  | Fluorescein mono(2-ethylamine) | 64,000/0.7mg | >95% | 1.6 |
| 05138 |  | Fluorescein bis(2-ethylamine) | 64,000/0.7mg | >95% | 9.4 |
| 05130 |  | Suflo-Cy3 | 64,000/0.7mg | >95% | 4.7 |
| 05120 |  | Fluorescein bis(Et-NHTrt) | 63,400/10mg | >95% | 164.5 |
| 05117 |  | Sulfofluorescein monoacetic acid | 68,800/0.1mg | >95% | 2.0 |
| 05116 |  | Sulfofluorescein diacetic acid | 81,100/0.1mg | >95% | 0 |
| 04923 |  | Ethanone, 1-benzo[a]pyren-1-yl- | 64,600/0.5mg | >95% | 654.9 |
| 04911 |  | Mono-6-ATTO550-beta-cyclodextrin(maleimide-conjugation) | 76,000/0.1mg | <80% | 0.1 |
| 04910 |  | Mono-6-NH-Cy3-beta-cyclodextrin(maleimide-conjugation) | 105,500/0.1mg | <80% | 0.1 |
| 04868 |  | Sulfofluorescein monoacetic acid tBuester | 64,000/0.7mg | >95% | 38.9 |
| 04867 |  | Fluocescein monoacetic acid | 72,300/2.5mg | >95% | 2.4 |
| 04866 |  | Fluocescein diacetic acid | 72,300/2.5mg | >95% | 10.3 |
| 04865 |  | Fluocescein monoacetic acid tBuester | 72,300/2.5mg | >95% | 0 |
| 04864 |  | Fluocescein diacetic acid tBu ester | 72,300/2.5mg | >95% | 105.0 |
| 04856 |  | N3',N6'-dimethyl-N3',N6'-bis[2-(methylamino)ethyl]-1,1-dioxo-spiro[2,1-ramda-benzoxathiole-3,9'-xanthene]-3',6'-diamine | 64,200/0.5mg | >95% | 7.9 |
| 04852 |  | bis-(IAA-piperazinyl) sulforhodamine | 63,400/0.2mg | >95% | 0.9 |
| 04847 |  | 3',6'-di(piperazin-1-yl)spiro[2,1-ramda-benzoxathiole-3,9'-xanthene] 1,1-dioxide | 64,200/0.5mg | >90% | 16.0 |
| 04846 |  | dichloro-Sulfofluorescein | inquire | >90% | 234.4 |
| 04512 |  | BODIPY-3-OH | 64,600/0.5mg | >95% | 86.9 |
| 04473 |  | BODIPY 2-OH | 64,000/5mg | >95% | 268.7 |
| 04470 |  | BODIPY-4OH | 70,800/2.5mg | >95% | 87.7 |
| 04162 |  | Mono-6-Cy3-NH-beta-cyclodextrin(amide-conjugation) | inquire | <80% | 0.1 |
| 04161 |  | Mono-6-NH-ATTO647-beta-cyclodextrin(amide-conjugation) | 105,500/0.1mg | <80% | 0.1 |
| 03457 |  | 4-(2,2-difluoro-4,6,10,12-tetramethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.03,7]dodeca-1(12),4,6,8,10-pentaen-8-yl)-2-(hydroxymethyl)phenol | 64,600/0.5mg | >90% | 6.6 |
| 03455 |  | 8-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2,2-difluoro-4,6,10,12-tetramethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.03,7]dodeca-1(12),4,6,8,10-pentaene | 72,500/5mg | >90% | 23.0 |
| 03389 |  | DimethoxyPiller[4]arene[1]dansyl-O-anisole | 64,600/0.5mg | >90% | 5.9 |
| 02956 |  | DimethoxyPiller[4]arene[1]Di(dansyl-O)benzene | 64,600/0.5mg | >90% | 7.4 |
| 02816 |  | Compound-12 | 68,100/0.2mg | >80% | 2.5 |
| 02815 |  | Boron, [5-[(3,5-dimethyl-1H-pyrrol-2-yl-kN)(3,5-dimethyl-2H-pyrrol-2-ylidene-kN)methyl]-2-hydroxybenzaldehydato]difluoro-,(T-4)- | 64,600/0.5mg | >80% | 0 |
| 02425 |  | FITC isomer I | 64,000/0.7mg | >95% | 10.0 |
| 01980 |  | Cy3-halolinker | 63,400/0.2mg | >95% | 0.1 |
